Aerie Pharmaceuticals Inc

NASDAQ:AERI   11:45:13 AM EDT
17.34
+0.50 (+2.97%)
Products, Regulatory

Aerie Pharmaceuticals Announces U.S. Food And Drug Administration Approval Of Its Athlone, Ireland Facility

Published: 09/15/2020 10:51 GMT
Aerie Pharmaceuticals Inc (AERI) - Aerie Pharmaceuticals Announces U.S. Food and Drug Administration Approval of Its Athlone, Ireland Facility for Production of Rhopressa® (netarsudil Ophthalmic Solution) 0.02%.
Aerie Pharmaceuticals Announces U.S. Food and Drug Administration Approval of Its Athlone, Ireland Facility for Production of Rhopressa® (netarsudil Ophthalmic Solution) 0.02%.
Aerie Pharmaceuticals Inc - Expect to Begin Shipping Rhopressa to United States in Q4 of 2020.